ROYAL BANK OF CANADA - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 33 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,0000.0%1,317
-6.0%
0.00%
Q3 2022$1,0001,401
+107.9%
0.00%
Q2 2022$0
-100.0%
674
-72.9%
0.00%
Q1 2022$6,000
-84.6%
2,483
-69.6%
0.00%
Q4 2021$39,000
-11.4%
8,160
+49.2%
0.00%
Q3 2021$44,000
+120.0%
5,468
+84.4%
0.00%
Q2 2021$20,000
-37.5%
2,966
-24.9%
0.00%
Q1 2021$32,000
+113.3%
3,949
+111.4%
0.00%
Q4 2020$15,000
+1400.0%
1,868
+834.0%
0.00%
Q3 2020$1,000
-50.0%
200
-16.0%
0.00%
Q2 2020$2,0000.0%238
-27.7%
0.00%
Q1 2020$2,000
-88.9%
329
-85.6%
0.00%
Q4 2019$18,000
+800.0%
2,277
+1038.5%
0.00%
Q3 2019$2,0000.0%200
-42.4%
0.00%
Q2 2019$2,0000.0%347
+73.5%
0.00%
Q1 2019$2,000
+100.0%
2000.0%0.00%
Q4 2018$1,000
-98.1%
200
-96.3%
0.00%
Q3 2018$52,000
-58.1%
5,387
-54.1%
0.00%
Q2 2018$124,000
+6100.0%
11,726
+5763.0%
0.00%
Q1 2018$2,000200
+2400.0%
0.00%
Q4 2017$080.0%0.00%
Q3 2017$080.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Yu Fan 112,044$532,0006.17%
Aisling Capital Management LP 1,691,151$8,033,0002.83%
Bain Capital Life Sciences Investors, LLC 2,847,689$13,527,0001.07%
GREAT POINT PARTNERS LLC 910,251$4,324,0000.96%
Samsara BioCapital, LLC 883,720$4,198,0000.81%
Sio Capital Management, LLC 498,500$2,368,0000.71%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1,167,0000.53%
Nantahala Capital Management 2,813,560$13,364,0000.47%
Altium Capital Management LP 293,764$1,395,0000.38%
Lion Point Capital, LP 300,000$1,425,0000.38%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders